两步法经皮肝穿刺胆道镜取石术治疗复杂肝胆管结石的效果及安全性分析

段昌虎; 刘晓晨; 段建峰; 丁建龙; 赵喜荣; 杨帆; 吴林; 赵李飞; 邰升

doi:10.3969/j.issn.1001-5256.2021.11.029

两步法经皮肝穿刺胆道镜取石术治疗复杂肝胆管结石的效果及安全性分析

DOI: 10.3969/j.issn.1001-5256.2021.11.029

1.
西安交通大学医学部附属三二〇一医院肝胆胰脾外科，陕西汉中 723000
2.
哈尔滨医科大学附属第二医院肝胆外科，哈尔滨 150001

基金项目:

黑龙江省自然科学基金 (H2018025)

详细信息

通信作者:
刘晓晨，liuxiaochen@126.com

中图分类号: R657.42
计量
- 文章访问数: 485
- HTML全文浏览量: 325
- PDF下载量: 54
- 被引次数: 0
出版历程
- 收稿日期: 2021-04-04
- 录用日期: 2021-05-10
- 出版日期: 2021-11-20

Effectiveness and safety of two-step percutaneous transhepatic choledochoscopic lithotomy in treatment of complex hepatolithiasis

1.
Department of Hepatobiliary, Pancreatic and Splenic Surgery, 3201 Hospital of Xi'an Jiaotong University Health Science Center, Hanzhong, Shaanxi 723000, China
2.
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China

Research funding:

Natural Science Foundation of Heilongjiang (H2018025)

摘要

摘要: 目的探讨两步法经皮肝穿刺胆道镜取石术(PTCSL)治疗复杂肝胆管结石的效果。方法回顾性分析2018年1月—2020年6月西安交通大学医学部附属三二〇一医院收治的118例复杂肝胆管结石患者的临床资料，按手术方式分为PTCSL组(n=60)及手术组(n=58), 术后两组患者通过电话及门诊随访0.5~3年。对比分析两组一般资料、围术期指标(包括手术时间、术中出血量、切口长度、术后肛门恢复排气排便时间、腹腔引流管拔除时间、住院时间)，肝功能及炎性指标变化情况，术后并发症(胆漏、急性胆管炎、伤口感染、下肢静脉血栓形成)发生情况，结石清除率及复发率，生活质量等指标。计量资料两组间比较采用两独立样本t检验；组内不同时间段间比较采用配对t检验，计数资料两组间比较采用χ²检验。结果 PTCSL组在手术时间、术中出血量、切口长度、术后肛门恢复排气排便时间、腹腔引流管拔除时间均少于手术组(P值均＜0.05)。术后第1天，PTCSL组及手术组患者ALT水平均低于术前(P值均＜0.05)，AST水平低于术前(P值均＜0.05)，WBC水平高于术前(P值均＜0.05)；PTCSL组患者术后第1天ALT、AST、WBC水平均明显低于外科手术组(P值均＜0.05)。PTCSL组在术后胆漏(5.0% vs 17.2%)、急性胆管炎(3.3% vs 13.8%)、伤口感染(1.7% vs 10.3%)、下肢静脉血栓发生率(1.7% vs 12.1%)均低于外科手术组(P值均＜0.05)。PTCSL组结石清除率高于外科手术组(58.3% vs 37.9%)，PTCSL组远期结石复发率(10.0% vs 20.7%)低于手术组(P值均＜0.05)。PTCSL组术后各生存质量评分均高于手术组(P值均＜0.05)。结论针对复杂肝胆管结石，两步法PTCSL可有效清除结石，术后康复快，复发率及并发症发生率低，预后生活质量高，是一种有效的可供选择的手术方式。
- 胆石 /
- 两步法经皮肝穿刺胆道镜取石术 /
- 最小侵入性外科手术
Abstract: Objective To investigate the clinical effect of two-step percutaneous transhepatic choledochoscopic lithotomy (PTCSL) in the treatment of complex hepatolithiasis. Methods A retrospective analysis was performed for the clinical data of 118 patients with complex hepatolithiasis who were admitted to 3201 Hospital of Xi'an Jiaotong University Health Science Center from January 2018 to June 2020, and according to the surgical procedure, they were divided into PTCSL group with 60 patients and surgery group with 58 patients. All patients were followed up for half a year to 3 years via telephone and outpatient service. The two groups were compared in terms of general information, perioperative indicators (including time of operation, intraoperative blood loss, incision length, time to first flatus and time to first defecation after surgery, time to extraction of abdominal drainage tube, and length of hospital stay), changes in liver function and inflammatory indicators, postoperative complications (bile leakage, acute cholangitis, wound infection, and venous thrombosis of lower extremities), stone clearance rate and recurrence rate, and quality of life. The two-independent-samples t-test was used for comparison of continuous data between two groups; the paired t-test was used for comparison between different periods of time within group; the chi-square test was used for comparison of categorical data between two groups. Results Compared with the surgery group, the PTCSL group had significantly shorter time of operation, time to first flatus and time to first defecation after surgery, and time to extraction of abdominal drainage tube, a significantly lower intraoperative blood loss, and a significantly shorter incision length (all P < 0.05). On day 1 after surgery, both groups had significant reductions in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (P < 0.05) and a significant increase in white blood cell count (WBC) (P < 0.05), and the PTCSL group had significantly lower levels of ALT, AST, and WBC than the surgery group (all P < 0.05). Compared with the surgery group, the PTCSL group had significantly lower incidence rates of postoperative bile leakage (5.0% vs 17.2%, P < 0.05), acute cholangitis (3.3% vs 13.8%, P < 0.05), wound infection (1.7% vs 10.3%, P < 0.05), and venous thrombosis of lower extremities (1.7% vs 12.1%, P < 0.05). Compared with the surgery group, the PTCSL group had a significantly higher stone clearance rate (58.3% vs 37.9%, P < 0.05) and a significantly lower long-term stone recurrence rate (10.0% vs 20.7%, P < 0.05). The PTCSL group had significantly higher quality of life scores than the surgery group (all P < 0.05). Conclusion For the treatment of complex hepatolithiasis, two-step PTCSL can effectively remove stones, with the advantages of fast postoperative recovery, low recurrence rate and incidence rate of complications, and high quality of life, and therefore, it is an effective alternative surgical procedure.
- Gallstones /
- Two-Step Percutaneous Transhepatic Choledochoscopy /
- Minimally Invasive Surgical Procedures

HTML全文

图 1 胆肠吻合术后胆肠吻合口及肝内多发结石行PTCSL治疗前后对比

注：a.胆总管囊肿行胆肠Roux-en-Y术后因腹痛不适复查MRCP示胆肠吻合口处及肝内胆管多发结石；b.超声联合介入行经皮肝穿刺胆道置管；c.PTCSL术中胆道镜下液电碎石；d.术后复查肝内胆管及胆肠吻合口处未见结石残留。

下载: 全尺寸图片幻灯片

表 1 两组患者一般资料比较

项目	PTCSL组(n=60)	手术组(n=58)	统计值	P值
男/女(例)	32/28	29/29	χ²=0.131	0.717
年龄(岁)	60.75±14.54	60.95±16.01	t=-0.070	0.944
伴有慢性病[例(%)]	17(28.3)	16(27.6)	χ²=0.008	0.928
美国麻醉师协会评分Ⅲ级[例(%)]	2(3.3)	2(3.4)	χ²=0.001	0.972

下载: 导出CSV

表 2 两组患者围术期指标比较

项目	PTCSL组(n=60)	手术组(n=58)	t值	P值
手术时间(min)	95.33±20.56	150.21±21.43	-14.195	＜0.001
术中出血量(mL)	50.07±14.76	205.72±16.06	-54.850	＜0.001
切口长度(cm)	1.83±0.46	8.02±2.32	-19.923	＜0.001
术后肛门恢复排气排便时间(d)	0.97±0.37	1.91±0.35	-14.302	＜0.001
腹腔引流管拔除时间(d)	4.48±0.59	6.81±0.62	-21.045	＜0.001
住院时间(d)	12.63±2.48	12.24±3.96	0.642	0.522

下载: 导出CSV

表 3 两组患者围术期肝功能及炎性指标变化情况比较

项目	PTCSL组(n=60)	手术组(n=58)	t值	P值
ALT(U/L)
术前	169.32±67.74	175.80±68.31	-0.517	0.606
术后第1天	67.63±24.74¹⁾	84.90±40.53¹⁾	-2.805	0.006
AST(U/L)
术前	127.97±54.45	120.60±61.21	0.691	0.491
术后第1天	51.58±18.20¹⁾	82.93±44.41¹⁾	-4.987	＜0.001
WBC(×10⁹/L)
术前	8.96±3.78	9.08±4.28	-0.169	0.866
术后第1天	10.77±3.85¹⁾	13.74±4.61¹⁾	-3.809	＜0.001
注：与同组术前比较，1)P＜0.05。

下载: 导出CSV

表 4 两组患者术后并发症发生情况比较

术后并发症	PTCSL(n=60)	手术组(n=58)	χ²值	P值
胆漏[例(%)]	3(5.0)	10(17.2)	4.508	0.034
急性胆管炎[例(%)]	2(3.3)	8(13.8)	4.160	0.041
伤口感染[例(%)]	1(1.7)	6(10.3)	3.980	0.046
下肢静脉血栓[例(%)]	1(1.7)	7(12.1)	5.049	0.025

下载: 导出CSV

表 5 两组患者结石清除率及远期复发率比较

结石清除率及复发率	PTCSL(n=60)	手术组(n=58)	χ²值	P值
结石清除[例(%)]	35(58.3)	22(37.9)	10.92	＜0.001
结石复发[例(%)]	6(10.0)	12(20.7)	7.84	＜0.001

下载: 导出CSV

表 6 两组患者术后生存质量评分比较

评分	PTCSL(n=60)	手术组(n=58)	t值	P值
总分(分)
术前	83.85±7.29	83.36±6.22	0.391	0.697
术后	129.07±9.90¹⁾	110.74±8.07¹⁾	11.003	＜0.001
生理功能(分)
术前	8.70±2.14	8.33±1.888	1.003	0.318
术后	18.30±3.87¹⁾	15.12±3.26¹⁾	4.819	＜0.001
社会活动(分)
术前	13.15±2.70	12.66±3.01	0.942	0.348
术后	16.53±4.35¹⁾	14.48±4.42¹⁾	2.541	0.012
主观症状(分)
术前	51.42±4.50	51.95±5.09	-0.602	0.548
术后	74.47±6.93¹⁾	65.93±6.45¹⁾	6.920	＜0.001
心理情绪(分)
术前	10.58±3.00	10.43±3.00	0.276	0.783
术后	19.77±3.96¹⁾	15.21±3.76¹⁾	6.408	＜0.001
注：与同组术前比较，1)P＜0.05。

下载: 导出CSV

参考文献(17)

[1]	DA COSTA AC, SANTA-CRUZ F, SENA BF, et al. Dedifferentiated liposarcoma of the gallbladder: First reported case[J]. World J Surg Oncol, 2018, 16(1): 221. DOI: 10.1186/s12957-018-1520-5.
[2]	LIU XW, CHENG Y, GONG JP. Value of percutaneous transhepatic lithotripsy in treatment of hepatolithiasis[J]. J Clin Hepatol, 2019, 35(7): 1640-1643. DOI: 10.3969/j.issn.1001-5256.2019.07.048. 刘新文, 程瑶, 龚建平. 经皮经肝胆道镜碎石取石术治疗肝胆管结石的价值[J]. 临床肝胆病杂志, 2019, 35(7): 1640-1643. DOI: 10.3969/j.issn.1001-5256.2019.07.048.
[3]	LU H, YANG H, WU L, et al. A novel prognostic model for diagnosing atypical bile duct hyperplasia in patients with intrahepatic lithiasis[J]. Medicine (Baltimore), 2019, 98(17): e15364. DOI: 10.1097/MD.0000000000015364.
[4]	LI H, ZHENG J, CAI JY, et al. Laparoscopic VS open hepatectomy for hepatolithiasis: An updated systematic review and meta-analysis[J]. World J Gastroenterol, 2017, 23(43): 7791-7806. DOI: 10.3748/wjg.v23.i43.7791.
[5]	CHEN CH, LIN CL, KAO CH. Association between inflammatory bowel disease and cholelithiasis: A nationwide population-based cohort study[J]. Int J Environ Res Public Health, 2018, 15(3): 513. DOI: 10.3390/ijerph15030513.
[6]	Biliary Tract Group, Chinese Society of Surgery, Chinese Medical Association. The 2011 Chinese guidelines for the diagnosis and treatment of hepatolithiasis[M]. Beijing: People's Medical Publishing House(PMPH), 2011. 中华医学会外科学分会胆道外科学组. 2011中国肝胆管结石病诊断治疗指南[M]. 北京: 人民卫生出版社, 2011.
[7]	XIA L, XIA YJ, ZHANG L, et al. Diagnosis and treatment of intrahepatic cholangiocarcinoma: Current status and thoughts[J]. J Clin Hepatol, 2020, 36(10): 2380-2385. DOI: 10.3969/j.issn.1001-5256.2020.10.048. 夏龙, 夏医君, 张磊, 等. 肝内胆管细胞癌的诊疗现状与思考[J]. 临床肝胆病杂志, 2020, 36(10): 2380-2385. DOI: 10.3969/j.issn.1001-5256.2020.10.048.
[8]	CHEN ZS, TANG CW, TANG CH, et al. Research advances in the clinical diagnosis of intrahepatic cholangiocarcinoma[J]. J Clin Hepatol, 2019, 35(12): 2638-2643. DOI: 10.3969/j.issn.1001-5256.2019.12.005. 陈志升, 唐陈伟, 汤朝晖, 等. 肝内胆管癌的临床诊断策略[J]. 临床肝胆病杂志, 2019, 35(12): 2638-2643. DOI: 10.3969/j.issn.1001-5256.2019.12.005.
[9]	WANG ZC. Curative effect of ERCP on senile patients with choledocholithiasis and its effect on serum inflammatory factors[J]. Traum Crit Med, 2019, 7(4): 233-235. DOI: 10.16048/j.issn.2095-5561.2019.04.12. 王超智. 内镜下逆行胆胰管造影术对老年胆总管结石患者疗效研究[J]. 创伤与急危重病医学, 2019, 7(4): 233-235. DOI: 10.16048/j.issn.2095-5561.2019.04.12.
[10]	TIAN J, LI JW, CHEN J, et al. Laparoscopic hepatectomy with bile duct exploration for the treatment of hepatolithiasis: An experience of 116 cases[J]. Dig Liver Dis, 2013, 45(6): 493-498. DOI: 10.1016/j.dld.2013.01.003.
[11]	WANG P, SUN B, HUANG B, et al. Comparison between percutaneous transhepatic rigid cholangioscopic lithotripsy and conventional percutaneous transhepatic cholangioscopic surgery for hepatolithiasis treatment[J]. Surg Laparosc Endosc Percutan Tech, 2016, 26(1): 54-59. DOI: 10.1097/SLE.0000000000000222.
[12]	LU GS, WEN HQ, LIU YM. A experimental study on formation of fistula after percutaneous transhepatic cholangiodrainage (PTCD)[J]. China J Endosc, 2004, 10(11): 44-46, 50. DOI: 10.3969/j.issn.1007-1989.2004.11.016. 陆光生, 文辉清, 刘衍民. 经皮肝穿刺胆道引流管周瘘道形成的实验研究[J]. 中国内镜杂志, 2004, 10(11): 44-46, 50. DOI: 10.3969/j.issn.1007-1989.2004.11.016.
[13]	HAN ZM, SHENG YH, ZHANG FK. Comparison of clinical effects between two different paths of percutaneous transhepatic cholangioscopy in treating complicated intrahepatic and extrahepatic bile duct stones[J]. J Hepatobiliary Surg, 2016, 24(6): 422-425. DOI: 10.3969/j.issn.1006-4761.2016.06.007. 韩志敏, 盛银行, 张风奎. 经皮肝胆道镜术两种不同路径治疗复杂肝内外胆管结石的临床疗效比较[J]. 肝胆外科杂志, 2016, 24(6): 422-425. DOI: 10.3969/j.issn.1006-4761.2016.06.007.
[14]	JIANG XF, ZHANG DW, LU HW, et al. Clinical effective analysis of percutaneous transhepatic cholangioscopic lithotrip by rigid choledochoscopy for 194 patients with intrahepatic stones[J]. Chin J Pract Surg, 2017, 37(8): 896-899. DOI: 10.19538/j.cjps.issn1005-2208.2017.08.16. 蒋小峰, 张大伟, 卢海武, 等. 经皮经肝胆道镜硬镜碎石术治疗肝内胆管结石194例临床疗效分析[J]. 中国实用外科杂志, 2017, 37(8): 896-899. DOI: 10.19538/j.cjps.issn1005-2208.2017.08.16.
[15]	LIU XY, LIU XM, ZHI XT. Comparative effect analysis on hepatolith patients by two different path percutaneous transhepatic cholangioscopic lithotripsy[J]. Chin J Curr Adv Gen Surg, 2015, 18(7): 530-532. DOI: 10.3969/j.issn.1009-9905.2015.07.009. 刘晓洋, 刘晓明, 智绪亭. 两种不同PTCSL路径治疗肝胆管结石的临床效果比较[J]. 中国现代普通外科进展, 2015, 18(7): 530-532. DOI: 10.3969/j.issn.1009-9905.2015.07.009.
[16]	TAO HS, WANG P, SUN BW, et al. One-Step multichannel percutaneous transhepatic cholangioscopic lithotripsy applied in bilateral hepatolithiasis[J]. World J Surg, 2020, 44(5): 1586-1594. DOI: 10.1007/s00268-020-05368-7.
[17]	WU C, YOU W, ZHANG L, et al. Clinical efficacy of percutaneous transhepatic lithotripsy with one-step biliary fistulation for the treatment of hepatolithiasis[J]. Clin J Dig Surg, 2020, 19(8): 843-848. DOI: 10.3760/cma.j.cn115610-20200603-00416. 吴琛, 游伟, 张龙, 等. Ⅰ期经皮经肝胆道造瘘胆道镜取石术治疗肝胆管结石病的临床疗效[J]. 中华消化外科杂志, 2020, 19(8): 843-848. DOI: 10.3760/cma.j.cn115610-20200603-00416.